Ó¢¹ú365¼¯ÍŹÙÍø

²úÆ·ÖÐÐÄ

ÁªÏµÓ¢¹ú365¼¯ÍŹÙÍø

+86-010-82156767

ÏúÊÛרÓãº

+86-010-62983737 

+86-15522507305 

+86-15522507319 

+86-15522507326

µØÖ·£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã

³¤Ð§¶àëÄÖ¬·¾Ëá²àÁ´

ÒȸßѪÌÇËØÑùëÄ-1£¨Glucagon-like Peptide-1, GLP-1£©ÊÇÓÉÈ˳¦µÀÉø͸µÄÒ»ÖÖëÄÀ༤ËØ£¬Ëü¿É´Ì¼¤Òȵºβϸ°ûÉø͸ÒȵºËØ£¬¼ÓÈëÌåÄÚѪÌÇƽºâµ÷Àí¡£GLP-1ÊÜÌ弤¶¯¼ÁÒѱ»ÆÕ±éÓ¦ÓÃÓÚ2ÐÍÌÇÄò²¡ºÍ·ÊÅÖµÄÖÎÁÆ¡£

ʹÓÃÖ¬·¾Ëá²àÁ´ÐÞÊÎÊÖÒÕ£¬¿ÉʵÏÖGLP-1ÀàËÆÎïµÄ³¤Ð§»¯£¬¼«´óÌá¸ß»¼ÕßÒÀ´ÓÐÔ¡£Ö¬·¾ËáÄܹ»ÒÔ¿ÉÄæµÄ·½·¨ÓëѪ½¬°×ÂÑ°×£¨human serum albumin£¬HSA£©ÍŽá£¬±£»¤¶àëÄÃâÊÜDPP-IV ½µ½âºÍÉö¹ýÂË£¬´Ó¶øÑÓÉìÒ©Îï°ëË¥ÆÚ¡£

ÏÖÔÚÊг¡Ö÷Á÷³¤Ð§GLP-1ÊÜÌ弤¶¯¼Á£¬ÈçÀûÀ­Â³ëÄ£¨Liraglutide£©¡¢Ë¾ÃÀ¸ñ³ëÄ£¨Semaglutide£© ºÍÌæ¶û²´ëÄ£¨Tirzepatide£©,¾ù½ÓÄÉÖ¬·¾Ëá²àÁ´ÐÞÊÎÊÖÒÕ¡£

 

Fig 1˾ÃÀ¸ñ³ëĺÍÌæ¶û²´ëĽṹ

Fig 1 The Structure of Semaglutide and Tirzepatide

Ó¢¹ú365¼¯ÍŹÙÍø¿Æ¼¼¿ÉÌṩʵÑéÊÒ¼°GMP¼¶±ðµÄ¸ßƱðÀ묷¾Ëá²àÁ´²úÆ·£¬Æä׿ԽµÄ´¿¶ÈºÍ´ó¹æÄ£µÄÉú²úÄÜÁ¦£¬È·±£Á˲úÆ·µÄÒ»ÖÂÐԺͿɿ¿ÐÔ£¬µ¥Åú´Î²úÁ¿¿ÉµÖ´ï10¹«½ï£¬²¢¿ÉÀ©Õ¹ÖÁ100¹«½ï£¬Öª×ãÄú´ÓÔçÆÚÒ©ÎïÑз¢µ½ÉÌÒµ»¯Éú²úÈ«Á÷³ÌµÄÐèÇó¡£

¹«Ë¾³Ð¼Ì“ÒÔÖÊÁÏÁ¢ÒìÒýÁìÉúÎïÒ½Ò©Á¢Ò씵Ä×ÚÖ¼£¬×¢ÖØÊÖÒÕÑз¢£¬ÈçÄúÐèÒªÆäËüδÁгöµÄ½á¹¹£¬»¶Ó­ÄúÀ´µç×Éѯ£¬Ó¢¹ú365¼¯ÍŹÙÍø¿Æ¼¼¿ÉÌṩ²àÁ´Àà²úÆ·µÄ¶¨ÖƺϳɷþÎñ£¬ÎªÄúµÄÑз¢ÏîÄ¿ÌṩÖÜÈ«Ö§³Ö¡£

ÐòºÅ

Æ·Ãû

´úºÅ

½á¹¹Ê½

´¿¶È

+

tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

¡Ý98%

OH-Ste-Glu(AEEA-AEEA-OSu)-OH

¡Ý90%

tBuO-Ste-Glu(AEEA-AEEA-OSu)-OtBu

¡Ý95%

Fmoc-Lys(tBuO-Ste-Glu(AEEA-AEEA)-OtBu)-OH

¡Ý98%

tBuO-ICO-Glu(AEEA-AEEA-OH)-OtBu

¡Ý98%

OH-ICO-Glu(AEEA-AEEA-OSu)-OH

¡Ý90%

tBuO-ICO-Glu(AEEA-AEEA-OSu)-OtBu

¡Ý95%

Fmoc-Lys(tBuO-ICO-Glu(AEEA-AEEA)-OtBu)-OH

¡Ý98%

< 1 > Ç°Íù Ò³
ÍøÕ¾µØͼ